- This event has passed.
Value & Innovation Biosimilars Seminar
Tuesday, June 2, 2020 @ 12:00 pm - 1:00 pm
Biosimilars continue to be a controversial subject long after Congress created a pathway for their approval. The Value & Innovation Forum prides itself on creating forums that present all sides of an issue as well as new and interesting angles beyond the hotly debated. Come join us for an hour of interesting discussion about the “rebate wall” controversy in biosimilars, a patient perspective, and where the FDA is headed next.
The Value & Innovation Forum, a Steering Committee comprised of representatives from the Alliance of Community Health Plans, Association of Black Cardiologists, Caregiver Action Network, National Forum for Heart Disease & Stroke Prevention, National Osteoporosis Foundation and the Patient Advocate Foundation invite you to participate in a webinar on
June 2, 2020, from 12:00-1:00 pm EDT.
BIOSIMILARS: THE NEXT FRONTIER
John M. Clymer, Executive Director, National Forum for Heart Disease & Stroke Prevention
Nicole Braccio, PharmD, Policy Director, National Patient Advocate Foundation
Christine Simmon, Senior Vice President, Policy & Strategic Alliances, Executive Director, Biosimilars Council, Association for Accessible Medicines
Sarah Yim, MD, Director, Office of Therapeutic Biologics and Biosimilars, Office of New Drugs, Center for Drug Evaluation & Research, U.S. Food and Drug Administration
Chad Pettit, Executive Director, Global Value Access and Policy, Amgen
Madelaine Feldman, MD, Practicing Rheumatologist and President, Coalition of State Rheumatology Organizations
To register for Biosimilars Seminar, click here. We look forward to you joining us.
For questions regarding this event, please reach out to Amina.Fahmy@connect4strategies.com.